# SolarWindow Technologies, Inc.: overview WNDW · OTC · CIK 1071840 · [Materials](/sectors/materials.md) · fiscal year ends Aug 31 Pages: [Overview](/companies/wndw.md) · [Financials](/companies/wndw/financials.md) · [Filings](/companies/wndw/filings.md) · [Insiders](/companies/wndw/insiders.md) Latest reported revenue: [$0](/filings/0001171843-24-006491.md) for Q4 FY2024, three months to 2024-08-31, from the 10-K filed Nov 20, 2024 (XBRL us-gaap:Revenues, accession 0001171843-24-006491). ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [0.0 d](/filings/0001171843-24-006491.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | [(0.01)](/filings/0001171843-26-000166.md) | [(0.01)](/filings/0001171843-26-002353.md) | [(0.01)](/filings/0001171843-26-004600.md) | not reported | [(0.01)](/filings/0001171843-26-000166.md) | [(0.01)](/filings/0001171843-26-002353.md) | [(0.01)](/filings/0001171843-26-004600.md) | | Free cash flow | $k | [(592) d](/filings/0001171843-25-007295.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-08-31) | FY2022 (2022-08-31) | FY2023 (2023-08-31) | FY2024 (2024-08-31) | FY2025 (2025-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | [0.0](/filings/0001171843-24-006491.md) | [0.0](/filings/0001171843-24-006491.md) | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.15)](/filings/0001171843-23-005488.md) | [(0.09)](/filings/0001171843-23-007232.md) | [(0.04)](/filings/0001171843-24-006491.md) | [(0.06)](/filings/0001171843-25-007295.md) | [(0.04)](/filings/0001171843-25-007295.md) | | Free cash flow | $k | [(2,736)](/filings/0001171843-23-005488.md) | [(3,998)](/filings/0001171843-23-007232.md) | [(2,085)](/filings/0001171843-24-006491.md) | [(1,743)](/filings/0001171843-25-007295.md) | [(1,540)](/filings/0001171843-25-007295.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wndw/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [McIlrath & Eck, LLC](/funds/1701714.md) | 2026-03-31 | $400 | 1,000 | | Not compared | | [Winch Advisory Services, LLC](/funds/1585822.md) | 2026-06-30 | $59 | 216 | | Unchanged | ## Recent filings [All 473 filings](/companies/wndw/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-07-13 | 15:24 ET | [10-Q](/filings/0001171843-26-004600.md) | Quarterly report, period 2026-05-31 | 0001171843-26-004600 | | 2026-04-29 | 16:11 ET | [S-1/A](/filings/0001171843-26-002824.md) | Registration statement, amended | 0001171843-26-002824 | | 2026-04-09 | 15:43 ET | [10-Q](/filings/0001171843-26-002353.md) | Quarterly report, period 2026-02-28 | 0001171843-26-002353 | | 2026-03-20 | 14:30 ET | [S-1/A](/filings/0001171843-26-001816.md) | Registration statement, amended | 0001171843-26-001816 | | 2026-01-09 | 14:20 ET | [10-Q](/filings/0001171843-26-000166.md) | Quarterly report, period 2025-11-30 | 0001171843-26-000166 | | 2025-12-12 | 15:58 ET | [8-K](/filings/0001171843-25-007912.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007912 | | 2025-11-26 | 15:46 ET | [8-K](/filings/0001171843-25-007625.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-007625 | | 2025-11-13 | 17:18 ET | [10-K](/filings/0001171843-25-007295.md) | Annual report, period 2025-08-31 | 0001171843-25-007295 | | 2025-10-09 | 15:59 ET | [S-1](/filings/0001171843-25-006379.md) | Registration statement | 0001171843-25-006379 | | 2025-08-07 | 19:05 ET | [8-K](/filings/0001171843-25-005136.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-005136 | ## Latest annual report [Form 10-K for the fiscal year ended Aug 31, 2025](/filings/0001171843-25-007295.md), filed Nov 13, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1071840 - Tickers: WNDW - Exchange: OTC - SIC code: 2860 Industrial Organic Chemicals - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.